About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chan Zuckerberg Initiative Joins Scale Bio's '100 Million Cell Challenge' to Accelerate Single Cell Genomics Research

By: via Business Wire

Scale Biosciences (Scale Bio), a leader in innovative and scalable single cell analysis solutions, today announced that the Chan Zuckerberg Initiative (CZI) has joined as a partner in the groundbreaking '100 Million Cell Challenge.' CZI will fully subsidize support for 50 million cells' worth of awarded projects. This partnership comes on the heels of an overwhelming response to the challenge, with researchers pledging to analyze over 100 million cells within days of the initial announcement.

The '100 Million Cell Challenge,' launched last month, aims to push the boundaries of single cell genomics research by encouraging large-scale projects across diverse biological systems. With the support of CZI and other program collaborators, Ultima Genomics and NVIDIA, the initiative is poised to make an even greater impact on the scientific community, helping to increase our understanding of complex biological systems and catalyze new discoveries, from basic research to translational medicine.

"Scale Bio's visionary '100 Million Cell Challenge' aligns with our efforts to support the single cell research community and create foundational resources that accelerate science," said Jonah Cool, Cell Science Senior Program Officer at the Chan Zuckerberg Initiative. "We're excited to support scientists to participate in this groundbreaking challenge and to make this research publicly available on Chan Zuckerberg Cell by Gene Discover, a tool we built that allows researchers to explore and draw new insights from cellular data." CZI will also use this data to contribute to a knowledge base for building AI-powered virtual cells to help scientists explore the molecular underpinnings of human health and disease.

Giovanna Prout, CEO of Scale Bio, expressed her enthusiasm for the partnership: "CZI's commitment to this challenge not only validates the importance of large-scale single cell studies, it also significantly expands the scope of what researchers can achieve. Through the 100 million cell challenge, Scale Bio and our collaborators hope to catalyze discoveries that could reshape precision medicine and our understanding of complex biological systems."

The scientific community has responded with overwhelming interest, submitting 40 projects spanning a wide spectrum of research disciplines. The submitted projects demonstrate the breadth and depth of potential applications for large-scale single cell analysis. Researchers have proposed studies ranging from creating comprehensive atlases of various organ systems to investigating cellular heterogeneity in disease states and exploring cross-species comparisons in regenerative processes.

The '100 Million Cell Challenge' is enabled by Scale Bio's new QuantumScale technology, a single cell RNA sequencing solution capable of processing up to 2 million cells per run. This new workflow was designed to empower researchers to pursue ambitious, large-scale single cell omics projects by offering unparalleled library preparation efficiency, top notch data quality, and low costs.

The challenge is continuing to accept proposals until October 15, 2024, at midnight PDT. Projects proposing to analyze 1 million cells or more are eligible for consideration. Selected projects will be announced at the American Society of Human Genetics (ASHG) Annual Meeting in November 2024.

To provide more information about the '100 Million Cell Challenge,' Scale Bio will host a live web broadcast featuring representatives from collaborating partners. This event will offer researchers an opportunity to learn more about the challenge, the application process and how projects will be selected. To register for the live web broadcast at 11:30 am PDT on September 24, 2024, please visit bit.ly/100MCell-Webcast.

For more information about the '100 Million Cell Challenge' and to submit a proposal, visit scale.bio/100MillionCells.

About Scale Biosciences

At Scale Bio, we are committed to accelerating scientific breakthroughs by providing innovative single cell omics solutions that redefine accessibility, flexibility, and scalability, empowering researchers to unlock the full potential of single cell omics. Leveraging our core massively parallelized single cell barcoding technology, we offer a range of advanced workflow solutions that maximize insights delivered with every experiment and sample type, allowing scientists to generate more data, analyze more samples, and explore more omics, cost efficiently and with unprecedented ease. Founded by scientists and technologists with experience across a range of multiomics disciplines, Scale Bio has attracted financing from leading life sciences tools investors including ARCH Venture Partners, BNG01, and Tao Capital. Scale Bio is headquartered in San Diego, Calif. Visit scale.bio to learn more.

About the Chan Zuckerberg Initiative

The Chan Zuckerberg Initiative was founded in 2015 to help solve some of society’s toughest challenges — from eradicating disease and improving education, to addressing the needs of our local communities. Our mission is to build a more inclusive, just, and healthy future for everyone. For more information, please visit chanzuckerberg.com.

Contacts

More News

View More
SoundHound Breaks Critical Resistance: How High Can It Get Now?
Via MarketBeat
Topics Artificial Intelligence
Tickers SOUN
Klarna IPO: BNPL Stock or Something Bigger?
Via MarketBeat
Topics Artificial Intelligence Initial Public Offering
Tickers AFRM KLAR
Why Teradyne Is a Core Play in the AI Hardware Boom
Via MarketBeat
Topics Artificial Intelligence Economy
Tickers TER
Meta Debuts Next-Gen AI Glasses—A Turning Point for Reality Labs?
Via MarketBeat
Topics Artificial Intelligence
Tickers AAPL META
How IREN is Building an AI Powerhouse on a Bitcoin Foundation
Via MarketBeat
Topics Artificial Intelligence Supply Chain
Tickers IREN NVDA
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.